PMDA drug package insert
ベスレミ皮下注250μgシリンジ
PMDA Prescription drug · ファーマエッセンシアジャパン株式会社 · package insert Aug 24, 2026
Key facts
| Brand names | ベスレミ皮下注250μgシリンジ, ベスレミ皮下注500μgシリンジ |
|---|---|
| Nonproprietary names | ロペグインターフェロン アルファ－２ｂ（遺伝子組換え） |
| Companies | 製造販売元／ファーマエッセンシアジャパン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 抗悪性腫瘍剤/ロペグインターフェロンα-2b製剤 |
| Therapeutic category codes | 874291 |
| YJ codes | 4291467G1021, 4291467G2028 |
| Approval numbers | 30500AMX00115000, 30500AMX00116000 |
| Package insert edition | 第5版 |
| Package insert date | Aug 24, 2026 |
| PMDA document key | 672247_4291467G1021_1 |
| PMDA company code | 672247 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: